Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

[1]  M. Geyer,et al.  Structural and Functional Analysis of the Cdk13/Cyclin K Complex. , 2016, Cell reports.

[2]  A. Greenleaf,et al.  Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas. , 2015, Biochimica et biophysica acta.

[3]  Tina Lenasi,et al.  Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex , 2015, Nucleic acids research.

[4]  A. Shilatifard,et al.  Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing , 2015, Molecular and Cellular Biology.

[5]  Yan Liu,et al.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. , 2014, Cancer cell.

[6]  A. Greenleaf,et al.  Expression, Purification, and Identification of Associated Proteins of the Full-length hCDK12/CyclinK Complex* , 2014, The Journal of Biological Chemistry.

[7]  N. Krogan,et al.  Cyclin-Dependent Kinase 12 Increases 3′ End Processing of Growth Factor-Induced c-FOS Transcripts , 2014, Molecular and Cellular Biology.

[8]  R. Young,et al.  An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element , 2014, Science.

[9]  Bandana Sharma,et al.  CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer , 2014, Cell.

[10]  Sridhar Ramaswamy,et al.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor , 2014, Nature.

[11]  W. G. Kelly,et al.  RNA Polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation , 2014, Nucleus.

[12]  D. Eick,et al.  The structure and substrate specificity of human Cdk12/Cyclin K , 2014, Nature Communications.

[13]  L. Karnitz,et al.  Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors* , 2014, The Journal of Biological Chemistry.

[14]  Lisa Muniz,et al.  3′ end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells , 2014, Genes & development.

[15]  Melissa J. Landrum,et al.  RefSeq: an update on mammalian reference sequences , 2013, Nucleic Acids Res..

[16]  Alan Ashworth,et al.  Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. , 2014, Cancer research.

[17]  M. Sansó,et al.  Pause, play, repeat , 2013, Transcription.

[18]  Philip R. Evans,et al.  How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.

[19]  A. Greenleaf,et al.  A DNA Damage Response System Associated with the phosphoCTD of Elongating RNA Polymerase II , 2013, PloS one.

[20]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[21]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[22]  Chao Zhang,et al.  Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II , 2012, Nature Structural &Molecular Biology.

[23]  David A. Orlando,et al.  Revisiting Global Gene Expression Analysis , 2012, Cell.

[24]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[25]  M. Marra,et al.  Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II , 2012, Molecular and Cellular Biology.

[26]  Richard A Young,et al.  Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. , 2012, Cancer cell.

[27]  M. Geyer,et al.  Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition , 2012, Nature Communications.

[28]  Taebo Sim,et al.  Discovery of potent and selective covalent inhibitors of JNK. , 2012, Chemistry & biology.

[29]  Jernej Ule,et al.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. , 2011, Genes & development.

[30]  N. Gray,et al.  In situ kinase profiling reveals functionally relevant properties of native kinases. , 2011, Chemistry & biology.

[31]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[32]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[33]  J. Lis,et al.  CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. , 2010, Genes & development.

[34]  A. Kornblihtt,et al.  The carboxy terminal domain of RNA polymerase II and alternative splicing. , 2010, Trends in biochemical sciences.

[35]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[36]  W. Kabsch.  XDS , 2010, Acta crystallographica. Section D, Biological crystallography.

[37]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[38]  S. Buratowski.  Progression through the RNA polymerase II CTD cycle. , 2009, Molecular cell.

[39]  John T. Lis,et al.  Defining mechanisms that regulate RNA polymerase II transcription in vivo , 2009, Nature.

[40]  Jignesh R. Parikh,et al.  mzAPI: a new strategy for efficiently sharing mass spectrometry data , 2009, Nature Methods.

[41]  S. Ficarro,et al.  Improved electrospray ionization efficiency compensates for diminished chromatographic resolution and enables proteomics analysis of tyrosine signaling in embryonic stem cells. , 2009, Analytical chemistry.

[42]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[43]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[44]  P. Borst,et al.  High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs , 2008, Proceedings of the National Academy of Sciences.

[45]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[46]  K. Jones,et al.  The multi-tasking P-TEFb complex. , 2008, Current opinion in cell biology.

[47]  D. D. Bailey,et al.  Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction , 2008, PloS one.

[48]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[49]  A. Genevière,et al.  CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. , 2007, Biochemical and biophysical research communications.

[50]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[51]  Hung-Hsi Chen,et al.  Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation , 2006, Molecular and Cellular Biology.

[52]  L. Johnson,et al.  The crystal structure of human CDK7 and its protein recognition properties. , 2004, Structure.

[53]  S. Buratowski,et al.  Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. , 2004, Molecular cell.

[54]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[55]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[56]  J. Greenblatt,et al.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. , 2001, Genes & development.

[57]  Zhongqi Zhang,et al.  A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra , 1998, Journal of the American Society for Mass Spectrometry.

[58]  R. Young,et al.  RNA polymerase II. , 1991, Annual review of biochemistry.

[59]  M. Siciliano,et al.  Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.

[60]  E. F. ARMSTRONG,et al.  Annual Review of Biochemistry , 1944, Nature.